MetLife Investment Management, LLC - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 118 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$621,795
+39.0%
27,1230.0%0.01%
+66.7%
Q2 2023$447,258
+58.8%
27,123
+11.0%
0.00%
+50.0%
Q1 2022$281,572
+83.5%
24,442
+59.0%
0.00%
+100.0%
Q4 2021$153,413
-23.6%
15,3720.0%0.00%
-50.0%
Q3 2021$200,758
-33.3%
15,3720.0%0.00%
-33.3%
Q2 2021$300,984
-7.9%
15,3720.0%0.00%0.0%
Q1 2021$326,962
-28.5%
15,3720.0%0.00%
-40.0%
Q4 2020$457,010
+37.2%
15,3720.0%0.01%
+25.0%
Q3 2020$333,111
-2.8%
15,3720.0%0.00%0.0%
Q2 2020$342,796
+67.3%
15,372
+14.2%
0.00%
+33.3%
Q1 2020$204,937
-33.7%
13,4650.0%0.00%0.0%
Q4 2019$309,156
+27.2%
13,465
+19.6%
0.00%0.0%
Q3 2019$243,017
-1.9%
11,2560.0%0.00%0.0%
Q2 2019$247,630
+45.9%
11,256
+81.8%
0.00%
+50.0%
Q1 2019$169,723
+2.0%
6,1920.0%0.00%0.0%
Q4 2018$166,441
-7.9%
6,1920.0%0.00%0.0%
Q3 2018$180,621
-37.1%
6,192
-37.2%
0.00%
-33.3%
Q4 2017$287,0009,8620.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
TRV GP, LLC 2,981,437$86,969,00072.32%
MPM ASSET MANAGEMENT LLC 3,074,893$89,695,00060.73%
Foresite Capital Management IV, LLC 696,903$20,329,0006.66%
NEA Management Company, LLC 4,912,306$143,292,0006.18%
RA Capital Management 1,950,332$56,891,0003.04%
Trustees of Princeton University 47,643$1,390,0001.96%
Greylock XII GP LLC 54,749$1,597,0001.12%
Baker Brothers Advisors 2,708,200$78,998,0000.52%
Perceptive Advisors 664,186$19,374,0000.52%
Sofinnova Investments, Inc. 159,302$4,646,0000.41%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders